XRAY vs AZTA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

XRAY

60.2
AI Score
VS
XRAY Wins

AZTA

32.2
AI Score

Investment Advisor Scores

XRAY

60score
Recommendation
HOLD

AZTA

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY AZTA Winner
Forward P/E 7.4627 29.0698 XRAY
PEG Ratio 0.746 0.5263 AZTA
Revenue Growth -4.1% 12.0% AZTA
Earnings Growth 15.2% 8777.8% AZTA
Tradestie Score 60.2/100 32.2/100 XRAY
Profit Margin -15.0% -20.0% XRAY
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% AZTA 1M: +32.2% · 3M: +91.4%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

AZTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (19.5% over 20 days), RSI 79

RSI (14): 79.1 · Price: $37.40

Fundamentals Snapshot

Metric XRAY AZTA
Market Cap
Forward P/E 7.2 63.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.1% 0.0%
EPS -2.71 -2.52
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.